King Pharmaceuticals Inc Stock Fundamentals
KING PHARMACEUTICALS INC fundamentals help investors to digest information that contributes to KING PHARMACEUTICALS's financial success or failures. It also enables traders to predict the movement of KING Stock. The fundamental analysis module provides a way to measure KING PHARMACEUTICALS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to KING PHARMACEUTICALS stock.
KING |
KING PHARMACEUTICALS INC Company Profit Margin Analysis
KING PHARMACEUTICALS's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current KING PHARMACEUTICALS Profit Margin | 0.05 % |
Most of KING PHARMACEUTICALS's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, KING PHARMACEUTICALS INC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, KING PHARMACEUTICALS INC has a Profit Margin of 0.052%. This is much higher than that of the sector and significantly higher than that of the Pharmaceutical Products industry. The profit margin for all United States stocks is notably lower than that of the firm.
KING PHARMACEUTICALS INC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining KING PHARMACEUTICALS's current stock value. Our valuation model uses many indicators to compare KING PHARMACEUTICALS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across KING PHARMACEUTICALS competition to find correlations between indicators driving KING PHARMACEUTICALS's intrinsic value. More Info.KING PHARMACEUTICALS INC is currently regarded as number one stock in return on asset category among related companies. It is currently regarded as number one stock in profit margin category among related companies fabricating about 2.00 of Profit Margin per Return On Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value KING PHARMACEUTICALS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for KING PHARMACEUTICALS's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the KING PHARMACEUTICALS's earnings, one of the primary drivers of an investment's value.KING Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses KING PHARMACEUTICALS's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of KING PHARMACEUTICALS could also be used in its relative valuation, which is a method of valuing KING PHARMACEUTICALS by comparing valuation metrics of similar companies.KING PHARMACEUTICALS is currently under evaluation in profit margin category among related companies.
KING Fundamentals
| Return On Asset | 0.026 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 3.2 B | |||
| Shares Outstanding | 248.24 M | |||
| Price To Earning | 32.29 X | |||
| Price To Book | 1.29 X | |||
| Price To Sales | 1.72 X | |||
| Revenue | 1.78 B | |||
| Gross Profit | 1.15 B | |||
| EBITDA | 453.31 M | |||
| Net Income | 91.95 M | |||
| Cash And Equivalents | 545.31 M | |||
| Cash Per Share | 1.58 X | |||
| Total Debt | 428.23 M | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 2.27 X | |||
| Cash Flow From Operations | 430.73 M | |||
| Earnings Per Share | 0.34 X | |||
| Market Capitalization | 3.05 B | |||
| Total Asset | 3.33 B | |||
| Retained Earnings | 963.62 M | |||
| Working Capital | 632.95 M | |||
| Current Asset | 1.13 B | |||
| Current Liabilities | 496.9 M | |||
| Z Score | 4.2 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards KING PHARMACEUTICALS in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, KING PHARMACEUTICALS's short interest history, or implied volatility extrapolated from KING PHARMACEUTICALS options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the KING PHARMACEUTICALS INC information on this page should be used as a complementary analysis to other KING PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in KING Stock
If you are still planning to invest in KING PHARMACEUTICALS INC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KING PHARMACEUTICALS's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |